13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001687509
Total reported value
$10.9B
$10.9B
64 檔
28.4%
According to the latest 13F quarterly dataset, Rubric Capital Management LP managed an equity portfolio of $10.9B at the end of Q3 2024, spanning 64 distinct U.S. exchange-listed positions.
Rubric Capital Management LP executed strategic sector rebalancing during Q3 2024, establishing 9 new positions while fully exiting 12 holdings and trimming 14 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TLN | Talen Energy CORP | Stock-Utilities | 33.02% | +0.52% | — | |
| 2 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 4.70% | -0.03% | -7.28% | |
| 3 | GLNG | Golar LNG Limited | Stock-Energy | 4.33% | -1.06% | — | |
| 4 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 4.21% | +0.48% | -2.61% | |
| 5 | VST | Vistra CORP | Stock-Utilities | 4.10% | +0.22% | +60.12% | |
| 6 | VTRS | Viatris Inc | Stock-Healthcare | 3.81% | +0.19% | — | |
| 7 | QDEL | Quidelortho CORP | Stock-Other | 3.12% | -0.05% | +15.21% | |
| 8 | BGC | Bgc Group Inc-a | Stock-Financials | 2.54% | -0.08% | -10.67% | |
| 9 | FLR | Fluor CORP | Stock-Industrials | 2.16% | +2.41% | NEW | |
| 10 | LBTYA | Liberty Global Ltd. | Stock-Other | 1.90% | -0.28% | +0.09% | |
| 11 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 1.66% | -0.07% | +11.71% | |
| 12 | MD | Pediatrix Medical Group Inc | Stock-Other | 1.56% | — | +1.53% | |
| 13 | 07WA | Mr Cooper Group Inc | Stock-Other | 1.56% | — | -31.79% | |
| 14 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 1.45% | +0.16% | — | |
| 15 | RNW | ReNew Energy Global Plc | Stock-Other | 1.40% | +0.10% | +1.48% | |
| 16 | ALIT | Alight Inc - Class A | Stock-Other | 1.40% | — | +38.27% | |
| 17 | DOLE | Dole plc | Stock-Other | 1.36% | — | — | |
| 18 | LBTYA | Liberty Global Ltd. | Stock-Other | 1.24% | -0.22% | +0.33% | |
| 19 | ADPT | Adaptive Biotechnologies | Stock-Other | 1.20% | — | +2.86% | |
| 20 | OPK | Opko Health Inc | Stock-Other | 1.18% | +0.08% | +9.64% | |
| 21 | SDGR | Schrodinger Inc | Stock-Other | 1.11% | +0.23% | +17.75% | |
| 22 | MATV | Mativ Holdings Inc | Stock-Other | 1.11% | -0.09% | — | |
| 23 | PTVEUSD | Pactiv Evergreen Inc | Stock-Other | 1.07% | — | — | |
| 24 | UAL | United Airlines Holdings Inc | Stock-Industrials | 1.03% | — | — | |
| 25 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 1.03% | -0.01% | — | |
| 26 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 0.99% | +0.44% | — | |
| 27 | EXTR | Extreme Networks Inc | Stock-Other | 0.96% | — | -25.17% | |
| 28 | CAR | Avis Budget Group Inc | Stock-Other | 0.96% | — | -2.59% | |
| 29 | TAC | Transalta CORP | Stock-Other | 0.95% | +0.10% | +19.97% | |
| 30 | OFIX | Orthofix Medical Inc | Stock-Other | 0.94% | -0.14% | — | |
| 31 | ADEA | Adeia Inc | Stock-Other | 0.90% | -0.45% | — | |
| 32 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.87% | -0.13% | — | |
| 33 | SSYS | Stratasys Ltd. | Stock-Other | 0.84% | -0.03% | +3.72% | |
| 34 | ZYME | Zymeworks Inc | Stock-Other | 0.80% | -0.18% | — | |
| 35 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 0.79% | -0.03% | -46.43% | |
| 36 | THS | Treehouse Foods Inc | Stock-Other | 0.78% | — | — | |
| 37 | XPER | Xperi Inc | Stock-Other | 0.62% | +0.06% | — | |
| 38 | TDOC | Teladoc Health Inc | Stock-Healthcare | 0.62% | — | -10.84% | |
| 39 | DK | Delek US Holdings Inc | Stock-Other | 0.61% | -0.03% | — | |
| 40 | GDRX | Goodrx Holdings Inc-class A | Stock-Other | 0.53% | — | +25.24% | |
| 41 | AIR | Aar CORP | Stock-Industrials | 0.50% | — | -17.97% | |
| 42 | FIP | Ftai Infrastructure Inc | Stock-Other | 0.48% | — | -1.35% | |
| 43 | CNNE | Cannae Holdings Inc | Stock-Other | 0.44% | — | — | |
| 44 | CSTM | Constellium SE | Stock-Other | 0.40% | — | -58.40% | |
| 45 | SCPH | Scpharmaceuticals Inc | Stock-Other | 0.35% | — | +35.46% | |
| 46 | ARDX | Ardelyx Inc | Stock-Other | 0.34% | +0.64% | +68.46% | |
| 47 | TRVI | Trevi Therapeutics Inc | Stock-Other | 0.27% | -0.04% | — | |
| 48 | RSKD | Riskified Ltd. | Stock-Other | 0.26% | — | -19.02% | |
| 49 | EMBC | Embecta CORP | Stock-Healthcare | 0.25% | -0.10% | EXIT | |
| 50 | TSAT | Telesat CORP | Stock-Other | 0.21% | -0.32% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TLN | Talen Energy CORP | +33% | NEW | New buy |
| 2 | VST | Vistra CORP | +1.1% | +60.12% | Add |
| 3 | UAL | United Airlines Holdings Inc | +1% | NEW | New buy |
| 4 | THS | Treehouse Foods Inc | +0.8% | NEW | New buy |
| 5 | DK | Delek US Holdings Inc | +0.6% | NEW | New buy |
| 6 | EMBC | Embecta CORP | +0.3% | NEW | New buy |
| 7 | SEG | Seaport Entertainment Group | +0.1% | NEW | New buy |
| 8 | IART | Integra Lifesciences Holding | +0.1% | NEW | New buy |
| 9 | TAC | Transalta CORP | +0.1% | +19.97% | Add |
| 10 | ✓ | Seaport Entmt Group Inc | 0% | NEW | New buy |
| 11 | ZVRA | Zevra Therapeutics Inc | — | NEW | New buy |
| 12 | ✓ | Vincerx Pharma Inc | — | — | Unchanged |
| 13 | ARDX | Ardelyx Inc | 0% | +68.46% | Add |
| 14 | OVID | Ovid Therapeutics Inc | 0% | — | Unchanged |
| 15 | TSAT | Telesat CORP | 0% | — | Unchanged |
| 16 | CHRS 1.5 04-15-26Bond | Coherus Oncology Inc | 0% | — | Unchanged |
| 17 | TXMD | Therapeuticsmd Inc | 0% | — | Unchanged |
| 18 | ABUS | Arbutus Biopharma CORP | 0% | — | Unchanged |
| 19 | IMVT | Immunovant Inc | 0% | EXIT | Sold out |
| 20 | HOWL | Werewolf Therapeutics Inc | 0% | — | Unchanged |
| 21 | MD | Pediatrix Medical Group Inc | -0.1% | +1.53% | Add |
| 22 | SCPH | Scpharmaceuticals Inc | -0.1% | +35.46% | Add |
| 23 | QDEL | Quidelortho CORP | -0.1% | +15.21% | Add |
| 24 | ZYME | Zymeworks Inc | -0.1% | — | Unchanged |
| 25 | MYPS | Playstudios Inc | -0.1% | — | Unchanged |
| 26 | OABI | Omniab Inc | -0.1% | — | Unchanged |
| 27 | BCYC | Bicycle Therapeutics Plc-adr | -0.1% | EXIT | Sold out |
| 28 | TRVI | Trevi Therapeutics Inc | -0.1% | — | Unchanged |
| 29 | ADPT | Adaptive Biotechnologies | -0.1% | +2.86% | Add |
| 30 | SPRY | Ars Pharmaceuticals Inc | -0.1% | EXIT | Sold out |
| 31 | PTGX | Protagonist Therapeutics Inc | -0.2% | EXIT | Sold out |
| 32 | RVNCEUR | Revance Therapeutics Inc | -0.2% | EXIT | Sold out |
| 33 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.2% | — | Unchanged |
| 34 | ALIT | Alight Inc - Class A | -0.2% | +38.27% | Add |
| 35 | ✓ | Playa Hotels & Resorts NV | -0.2% | EXIT | Sold out |
| 36 | GDRX | Goodrx Holdings Inc-class A | -0.2% | +25.24% | Add |
| 37 | FIP | Ftai Infrastructure Inc | -0.2% | -1.35% | Trim |
| 38 | CNNE | Cannae Holdings Inc | -0.2% | — | Unchanged |
| 39 | XPER | Xperi Inc | -0.3% | — | Unchanged |
| 40 | OPK | Opko Health Inc | -0.3% | +9.64% | Add |
| 41 | DOLE | Dole plc | -0.3% | — | Unchanged |
| 42 | CHRS | Coherus Oncology Inc | -0.3% | — | Unchanged |
| 43 | AMRX | Amneal Pharmaceuticals Inc | -0.3% | — | Unchanged |
| 44 | OFIX | Orthofix Medical Inc | -0.3% | — | Unchanged |
| 45 | KOP | Koppers Holdings Inc | -0.4% | EXIT | Sold out |
| 46 | SSTK | Shutterstock Inc | -0.4% | EXIT | Sold out |
| 47 | CRS | Carpenter Technology | -0.4% | EXIT | Sold out |
| 48 | LBTYA | Liberty Global Ltd. | -0.4% | +0.33% | Add |
| 49 | MREO | Mereo Biopharma Group Pl-adr | -0.4% | — | Unchanged |
| 50 | RSKD | Riskified Ltd. | -0.4% | -19.02% | Trim |
According to official SEC Form 13F filings, Rubric Capital Management LP reported a total U.S. public equity portfolio value of $10.9B across 64 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TLN, TEVA, GLNG) accounted for 28.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
TLN
市值: $2.0B
Top Position Liquidated / Trimmed
JAZZ
前期市值: $65.8M
During Q3 2024, Rubric Capital Management LP's top holdings by market value included TLN (33.0%)、TEVA (4.7%)、GLNG (4.3%). The largest single position, TLN, represented 33.0% of total portfolio value.
In Q3 2024, Rubric Capital Management LP made 51 total portfolio adjustments, initiating 9 new buys, adding to 16 positions, trimming 14 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.